Considerations in biomarker development for neurodevelopmental disorders. - Wikidata - awgldk - TriplyDB

Considerations in biomarker development for neurodevelopmental disorders.

Considerations in biomarker development for neurodevelopmental disorders.

http://www.wikidata.org/entity/Q36702733

about

Replicable in vivo physiological and behavioral phenotypes of the Shank3B null mutant mouse model of autism.The EU-AIMS Longitudinal European Autism Project (LEAP): design and methodologies to identify and validate stratification biomarkers for autism spectrum disorders.Rapid and Objective Assessment of Neural Function in Autism Spectrum Disorder Using Transient Visual Evoked Potentials.Defining Precision Medicine Approaches to Autism Spectrum Disorders: Concepts and Challenges Arbaclofen in Children and Adolescents with Autism Spectrum Disorder: A Randomized, Controlled, Phase 2 Trial.Developing Clinically Practicable Biomarkers for Autism Spectrum Disorder.Modulation of reward in a live social context as revealed through interactive social neuroscience.Electrophysiological response during auditory gap detection: Biomarker for sensory and communication alterations in autism spectrum disorder?Erythrocyte fatty acid profiles in children are not predictive of autism spectrum disorder status: a case control study.Atypicality of the N170 Event-Related Potential in Autism Spectrum Disorder: A Meta-analysis Applications of node-based resilience graph theoretic framework to clustering autism spectrum disorders phenotypes

P2860

Q33805524-110B7ADF-985C-41A3-9A87-74FBA158BED2 Q33827324-497A9FE2-FBBC-403D-A398-61A8D8A9D41E Q36157578-36DD5EFA-2A48-4B79-840F-7A858CDC4676 Q37447215-B331365C-ADDC-426B-81DF-140E907EE0F2 Q39283196-20B9161C-6E8B-432A-BEB1-F9E0672275E4 Q47671524-A6427634-F5B2-4566-A511-F290591EFA64 Q47837444-5F7C931F-D09A-4857-BA4D-F4E8F5C9BD46 Q50046919-7E617111-6421-4FC5-9201-4CF5A94D89C1 Q55317458-4887F5E5-A711-48FF-9074-BB16F814DF6F Q57171590-5B485108-4A90-43F1-9992-118D889FC252 Q58694149-85D86D92-45BD-4589-A092-0E75A072FACD

P2860

Considerations in biomarker development for neurodevelopmental disorders.

http://www.wikidata.org/entity/Q36702733

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

2016年论文

@zh

2016年论文

@zh-cn

name

Considerations in biomarker development for neurodevelopmental disorders.

@ast

Considerations in biomarker development for neurodevelopmental disorders.

@en

type

label

Considerations in biomarker development for neurodevelopmental disorders.

@ast

Considerations in biomarker development for neurodevelopmental disorders.

@en

prefLabel

Considerations in biomarker development for neurodevelopmental disorders.

@ast

Considerations in biomarker development for neurodevelopmental disorders.

@en

P1433

Q36702733-C64AB1FB-1023-4562-8DFC-A9E0790EF547

P1476

Q36702733-1A3ED7B5-3209-4AF6-BFE0-C5D8F98CCE8D

P2093

Q36702733-404D808A-EDC5-412D-94F9-BF1F07C28929

P2860

Q36702733-030F43E5-18BD-4173-A063-1CA579BCB42E

Q36702733-0C2961FC-4091-4329-8BF1-80720260AD59

Q36702733-0CC56567-294A-4503-AD77-F9F40E0E05CB

Q36702733-12E1BB93-AAA8-4881-BE60-64A77EA72109

Q36702733-1409E999-5B05-4D9D-9C73-82B9E98CBAE8

Q36702733-154BA063-FDFC-4937-9AB2-FC888DCED06D

Q36702733-1C89AD38-3DA5-478C-9F6F-F3B0D4C9BB5D

Q36702733-27090429-48A9-48C2-94F7-CCEB5224C933

Q36702733-289A2F69-6AFE-4448-953E-6E72B1CDED70

Q36702733-3546FEC4-365A-43D8-81AE-896F1B7D1A9C

P304

Q36702733-E914506C-52AD-4AC9-A107-50BA7DBE990F

P31

Q36702733-BF4749AC-714E-4F61-8143-BD1369739B0A

P356

Q36702733-568A333A-DB2A-4050-B7A6-C8B01AFFF480

P433

Q36702733-50A9E1F3-2A17-4D23-9771-4CF9A15AAA99

P478

Q36702733-214E2235-B5B4-436E-8692-9D7F5A61E8A4

P577

Q36702733-C2FD176D-81B5-40C5-AE25-A375EB018B7C

P698

Q36702733-312AD9FA-6BBC-4660-B050-2696A68C87E5

P921

Q36702733-9373A8E2-B3BF-4495-9408-5409BE4E553B

Q36702733-FF711B2C-EA16-4BBD-B3A1-FCCB9EDA5E64

P932

Q36702733-3B153633-94F7-48CD-BE94-7B264A1F6F9F

P356

WCO.0000000000000300

P1433

Current Opinion in Neurology

P1476

Considerations in biomarker development for neurodevelopmental disorders.

@en

P2093

James C McPartland

http://www.w3.org/2001/XMLSchema#string

P2860

Disruptive CHD8 mutations define a subtype of autism early in development

Autism Diagnostic Interview-Revised: a revised version of a diagnostic interview for caregivers of individuals with possible pervasive developmental disorders

Biomarkers in Pharmaceutical Research

Biomarkers and surrogate endpoints: preferred definitions and conceptual framework

Infantile autism: a genetic study of 21 twin pairs

Neurophysiological correlates of impaired facial affect recognition in individuals at risk for schizophrenia

Event-related potential examination of facial affect processing in bipolar disorder and schizophrenia

Sex differences in social perception in children with ASD.

Early visual ERPs are influenced by individual emotional skills.

Understanding the nature of face processing impairment in autism: insights from behavioral and electrophysiological studies.

P304

118-122

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1097/WCO.0000000000000300

http://www.w3.org/2001/XMLSchema#string

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

29

http://www.w3.org/2001/XMLSchema#string

P577

2016-02-03T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

26844621

http://www.w3.org/2001/XMLSchema#string

P921

neurodevelopmental disorders

P932

4798424

http://www.w3.org/2001/XMLSchema#string